Medicare Drug Plans Favor Generic Opioids Over Those Designed To Avoid Abuse, Study Finds
The Part D plans have cut back coverage of a newer version of OxyContin that has been formulated to make it tougher for people to snort or inject it. That new version is 20 times more expensive than the generic.